• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大按吸烟状况划分的患肺癌终生概率。

Lifetime probability of developing lung cancer, by smoking status, Canada.

作者信息

Villeneuve P J, Mao Y

机构信息

Bureau of Chronic Disease Epidemiology, Tunney's Pasture, Ottawa, Ontario.

出版信息

Can J Public Health. 1994 Nov-Dec;85(6):385-8.

PMID:7895211
Abstract

Life table methodology was used to estimate the probability of developing lung cancer by smoking status. Lifetime risks of developing lung cancer were estimated for six hypothetical cohorts (males, females, male current smokers, male never smokers, female current smokers, and female never smokers). Estimates of smoking mortality and incidence rates were calculated based on Canadian rates observed over the period 1987 to 1989. It was found that 172/1,000 of male current smokers will eventually develop lung cancer; the similar probability among female current smokers was 116/1,000. For those who never smoked on a regular basis the lifetime risk was substantially reduced. Only 13/1,000 males and 14/1,000 females in this category will develop lung cancer. When smoking status is not adjusted for, the lifetime risk of developing lung cancer is approximately 96/1,000 and 43/1,000 for males and females respectively.

摘要

生命表方法用于按吸烟状况估计患肺癌的概率。对六个假设队列(男性、女性、男性当前吸烟者、男性从不吸烟者、女性当前吸烟者和女性从不吸烟者)的肺癌终生风险进行了估计。吸烟死亡率和发病率的估计值是根据1987年至1989年期间加拿大观察到的发病率计算得出的。结果发现,每1000名男性当前吸烟者中有172人最终会患肺癌;女性当前吸烟者中的类似概率为每1000人中有116人。对于那些从不经常吸烟的人来说,终生风险大幅降低。这一类别中每1000名男性和女性中分别只有13人和14人会患肺癌。在不考虑吸烟状况的情况下,男性和女性患肺癌的终生风险分别约为每1000人中有96人和43人。

相似文献

1
Lifetime probability of developing lung cancer, by smoking status, Canada.加拿大按吸烟状况划分的患肺癌终生概率。
Can J Public Health. 1994 Nov-Dec;85(6):385-8.
2
Calculation of lifetime lung cancer risks associated with radon exposure, based on various models and exposure scenarios.基于各种模型和暴露场景计算与氡暴露相关的终生肺癌风险。
J Radiol Prot. 2015 Sep;35(3):539-55. doi: 10.1088/0952-4746/35/3/539. Epub 2015 Jun 17.
3
Predicting lung cancer deaths from smoking prevalence data.从吸烟流行数据预测肺癌死亡人数。
Lung Cancer. 2011 Nov;74(2):170-7. doi: 10.1016/j.lungcan.2011.02.011. Epub 2011 Mar 21.
4
Health consequences of smoking among Canadian smokers: An update.
Chronic Dis Can. 1999;20(1):36-9.
5
Cigarette smoking and lung cancer in New Mexico.新墨西哥州的吸烟与肺癌
Am Rev Respir Dis. 1988 May;137(5):1110-3. doi: 10.1164/ajrccm/137.5.1110.
6
Primary prevention, smoking, and smoking cessation: implications for future trends in lung cancer prevention.一级预防、吸烟与戒烟:对肺癌预防未来趋势的影响
Cancer. 2000 Dec 1;89(11 Suppl):2506-9. doi: 10.1002/1097-0142(20001201)89:11+<2506::aid-cncr33>3.3.co;2-#.
7
Lifetime risk and trends in lung cancer incidence in greater Mumbai.孟买大都市区肺癌的终生风险及发病率趋势。
Asian Pac J Cancer Prev. 2009 Jan-Mar;10(1):75-82.
8
The influence of life table corrections for smokers and nonsmokers on the health effects of radon using the BEIR (biological effects of ioniziing radiation) IV method.使用BEIR(电离辐射生物效应)IV方法对吸烟者和非吸烟者进行寿命表校正对氡健康影响的作用。
Health Phys. 1994 Jun;66(6):615-20. doi: 10.1097/00004032-199406000-00001.
9
Estimation of lifetime cumulative mortality risk of lung cancer by smoking status in Japan.日本基于吸烟状况估算的肺癌终生累积死亡率。
Jpn J Clin Oncol. 2020 Sep 28;50(10):1218-1224. doi: 10.1093/jjco/hyaa094.
10
Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung.肺原发性腺癌患者中从不吸烟者与当前吸烟者相比生存率提高。
Chest. 2004 Aug;126(2):347-51. doi: 10.1378/chest.126.2.347.

引用本文的文献

1
Risk characterization for silica-related silicosis and lung cancer in communities adjacent to sand and gravel extraction facilities: examining limitations in our current risk methods.砂石开采设施附近社区中与二氧化硅相关的矽肺病和肺癌的风险特征描述:审视我们当前风险评估方法的局限性
Front Public Health. 2025 Jun 18;13:1558778. doi: 10.3389/fpubh.2025.1558778. eCollection 2025.
2
Giving support to close others increases affective risk perceptions: longitudinal and experimental studies.支持亲密他人会增加情感风险感知:纵向研究与实验研究
J Behav Med. 2025 Jun;48(3):488-499. doi: 10.1007/s10865-025-00552-3. Epub 2025 Feb 22.
3
Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy.
纳米颗粒已从肺癌治疗的临床前研究进入临床试验阶段。
Cancer Nanotechnol. 2023;14(1):28. doi: 10.1186/s12645-023-00174-x. Epub 2023 Mar 28.
4
Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer.手术切除的非小细胞肺癌患者复发的预后因素。
Contemp Oncol (Pozn). 2022;26(3):239-246. doi: 10.5114/wo.2022.120638. Epub 2022 Oct 24.
5
DNA damage, DNA repair and carcinogenicity: Tobacco smoke versus electronic cigarette aerosol.DNA 损伤、DNA 修复与致癌性:烟草烟雾与电子烟气溶胶的对比。
Mutat Res Rev Mutat Res. 2022 Jan-Jun;789:108409. doi: 10.1016/j.mrrev.2021.108409. Epub 2021 Dec 20.
6
Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives.肺癌低剂量 CT 筛查与死亡率降低——证据、陷阱及未来展望。
Nat Rev Clin Oncol. 2021 Mar;18(3):135-151. doi: 10.1038/s41571-020-00432-6. Epub 2020 Oct 12.
7
Activity of Antioxidant Enzymes in the Tumor and Adjacent Noncancerous Tissues of Non-Small-Cell Lung Cancer.抗氧化酶在非小细胞肺癌肿瘤及相邻非癌组织中的活性。
Oxid Med Cell Longev. 2019 Oct 31;2019:2901840. doi: 10.1155/2019/2901840. eCollection 2019.
8
40 years of the human T-cell leukemia virus: past, present, and future.人类T细胞白血病病毒40年:过去、现在与未来
F1000Res. 2019 Feb 28;8. doi: 10.12688/f1000research.17479.1. eCollection 2019.
9
Recognising Lung Cancer in Primary Care.在初级保健中识别肺癌。
Adv Ther. 2019 Jan;36(1):19-30. doi: 10.1007/s12325-018-0843-5. Epub 2018 Nov 29.
10
Utility gains from reductions in the modifiable burden of lung cancer attributable to residential radon in Canada.加拿大住宅氡导致的肺癌可调整负担减少的实用增益。
Can J Public Health. 2018 Aug;109(4):598-609. doi: 10.17269/s41997-018-0119-5. Epub 2018 Sep 27.